EA201991340A1 - Способы индуцирования иммунологической толерантности к факторам свертывания крови - Google Patents

Способы индуцирования иммунологической толерантности к факторам свертывания крови

Info

Publication number
EA201991340A1
EA201991340A1 EA201991340A EA201991340A EA201991340A1 EA 201991340 A1 EA201991340 A1 EA 201991340A1 EA 201991340 A EA201991340 A EA 201991340A EA 201991340 A EA201991340 A EA 201991340A EA 201991340 A1 EA201991340 A1 EA 201991340A1
Authority
EA
Eurasian Patent Office
Prior art keywords
blood
coaging
factors
methods
immunological tolerance
Prior art date
Application number
EA201991340A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/064323 external-priority patent/WO2018102760A1/en
Publication of EA201991340A1 publication Critical patent/EA201991340A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

В настоящем изобретении предусмотрены способы индуцирования иммунологической толерантности у человека, включающие введение человеку эффективного количества композиции или химерного белка, содержащих фактор свертывания крови и Fc-область.
EA201991340A 2017-11-07 2017-12-01 Способы индуцирования иммунологической толерантности к факторам свертывания крови EA201991340A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762582829P 2017-11-07 2017-11-07
PCT/US2017/064323 WO2018102760A1 (en) 2016-12-02 2017-12-01 Methods of inducing immune tolerance to clotting factors

Publications (1)

Publication Number Publication Date
EA201991340A1 true EA201991340A1 (ru) 2019-11-29

Family

ID=68653614

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991340A EA201991340A1 (ru) 2017-11-07 2017-12-01 Способы индуцирования иммунологической толерантности к факторам свертывания крови

Country Status (1)

Country Link
EA (1) EA201991340A1 (ru)

Similar Documents

Publication Publication Date Title
GEP20217326B (en) Constructs having a sirp-alpha domain or variant thereof
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
WO2017134302A3 (en) Targeted therapeutic agents and uses thereof
EA201792221A1 (ru) Антитела против сортилина и способы их применения
EA201890145A1 (ru) Антитела к фактору xi и способы их применения
EA201791775A1 (ru) Цистеиновая протеаза
EA201890453A1 (ru) Анти-angptl8 антитела и их применение
PH12019502763A1 (en) Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereof
BR112016023948A2 (pt) proteínas fc multiméricas
MX2018009011A (es) Anticuerpos anti receptor 1 transmembrana de tirosina-proteina cinasa (ror1) y usos de los mismos.
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201991207A1 (ru) Новые агонисты tnfr и их применение
EA201591501A1 (ru) Терапевтические средства на основе csf-1
EA201690159A1 (ru) Способы и композиции для лечения рака
CY1124922T1 (el) Καινοτομος σταθερη φαρμακοτεχνικη μορφη για αντισωματα fxia
EA202190138A1 (ru) Анти-sirp-бета1 антитела и способы их использования
MX2022002635A (es) Anticuerpos anti proteina similar a angiopoyetina 4 y metodos de uso.
EA202092085A1 (ru) ТЕРАПЕВТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ sPLA2-GIB И ИХ ПРИМЕНЕНИЕ
MX2020007628A (es) Composiciones y metodos de uso.
WO2016061504A3 (en) Recombinant antibodies that recongnize the c-terminal domains of ebola virus nucleoprotein
TW201613977A (en) Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use
CL2020003355A1 (es) Proteínas inmunodominantes y fragmentos en esclerosis múltiple
MX2019006446A (es) Métodos para inducir tolerancia inmunológica a factores de coagulación.
EA202191758A1 (ru) Пептиды для лечения и профилактики диабета и связанных с ним заболеваний